Deadlines in March are Closer


Latest News	For the Leaders	Contact Us

Roche Unveils Promising Data for SMA and DMD at MDA 2025

Roche shared its five-year study on patients with Types 2 and 3 SMA who received Evrysdi and experienced long-term stabilization in motor function, a crucial milestone for those facing progressive muscle weakness.

Arvinas and Pfizer Announce Positive Phase 3 Results for Breast Cancer Therapy

The companies have reported positive topline results from the Phase 3 VERITAC-2 trial evaluating vepdegestrant in patients with advanced ER+/HER2- breast cancer. The study shows a significant improvement in progression-free survival for patients.

Cognizant And Boehringer Ingelheim Launch Unified Digital Platform To Streamline Drug Development

This platform is designed to modernise Boehringer’s drug development processes by replacing over 20 legacy platforms with a unified "One Medicine Platform." The goal is to streamline operations and improve cross-functional collaboration.

With the launch of the ‘Make in India’ initiative in 2014, the Indian pharmaceutical industry has experienced significant growth. On the grounds of CPHI, he dives deep into the key trends shaping the next decade (2024-2034), the opportunities for young professionals and investors, and the upsurge of India in the global game of Pharma.

Watch Now

As March draws to a close, it’s time to get on your toes!
Stay Tuned with Pharma Now
Until then, Adios!

Find us on:

Visit Pharma now

| Terms & Privacy |